Targeting histone deacetylases for heart failure

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.13, Iss.7, 2009-07, pp. : 767-784

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting Histone Deacetylases in Neuroblastoma

Current Pharmaceutical Design, Vol. 15, Iss. 4, 2009-02 ,pp. : 436-447

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting class I histone deacetylases in cancer therapy

By Delcuve Geneviève P Khan Dilshad H Davie James R

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 1, 2013-01 ,pp. : 29-41

Informa Healthcare

Access to resources Recommend Favorite

Targeting Histone Deacetylases for the Treatment of Immune, Endocrine & Metabolic Disorders

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 9, Iss. 1, 2009-03 ,pp. : 84-107

Bentham Science Publishers

Access to resources Recommend Favorite

Assays for Histone Deacetylases

Current Topics in Medicinal Chemistry, Vol. 9, Iss. 3, 2009-02 ,pp. : 227-234

Bentham Science Publishers

Access to resources Recommend Favorite

Agents targeting inflammation in heart failure

By Gullestad Lars Kjekshus John Damås Jan Kristian Ueland Thor Yndestad Arne Aukrust Pål

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 5, 2005-05 ,pp. : 557-566

Informa Healthcare

Access to resources Recommend Favorite